These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 34080649)
1. circSAMD4A participates in the apoptosis and autophagy of dopaminergic neurons via the miR‑29c‑3p‑mediated AMPK/mTOR pathway in Parkinson's disease. Wang W; Lv R; Zhang J; Liu Y Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34080649 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of miR‑185 inhibits autophagy and apoptosis of dopaminergic neurons by regulating the AMPK/mTOR signaling pathway in Parkinson's disease. Wen Z; Zhang J; Tang P; Tu N; Wang K; Wu G Mol Med Rep; 2018 Jan; 17(1):131-137. PubMed ID: 29115479 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA HAGLROS regulates apoptosis and autophagy in Parkinson's disease via regulating miR-100/ATG10 axis and PI3K/Akt/mTOR pathway activation. Peng T; Liu X; Wang J; Liu Y; Fu Z; Ma X; Li J; Sun G; Ji Y; Lu J; Wan W; Lu H Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2764-2774. PubMed ID: 31298038 [TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of osmotin in Parkinson's disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways. Park JS; Choe K; Lee HJ; Park TJ; Kim MO J Biomed Sci; 2023 Aug; 30(1):66. PubMed ID: 37568205 [TBL] [Abstract][Full Text] [Related]
6. miR-101a-3p/ROCK2 axis regulates neuronal injury in Parkinson's disease models. Tao X; Zhang W; Chen C; Tao Y; Tao Y; Chen Z; Zhang G Aging (Albany NY); 2024 May; 16(10):8732-8746. PubMed ID: 38775730 [TBL] [Abstract][Full Text] [Related]
7. MiR-181b regulates autophagy in a model of Parkinson's disease by targeting the PTEN/Akt/mTOR signaling pathway. Li W; Jiang Y; Wang Y; Yang S; Bi X; Pan X; Ma A; Li W Neurosci Lett; 2018 May; 675():83-88. PubMed ID: 29608948 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease. Yao L; Zhu Z; Wu J; Zhang Y; Zhang H; Sun X; Qian C; Wang B; Xie L; Zhang S; Lu G FASEB J; 2019 Jul; 33(7):8648-8665. PubMed ID: 30995872 [TBL] [Abstract][Full Text] [Related]
9. SNHG14 Elevates NFAT5 Expression Through Sequestering miR-375-3p to Promote MPP + -Induced Neuronal Apoptosis, Inflammation, and Oxidative Stress in Parkinson's Disease. Xu F; Bian N; Li X Neurochem Res; 2024 May; 49(5):1212-1225. PubMed ID: 38381247 [TBL] [Abstract][Full Text] [Related]
10. HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson's disease by elevating NPTX2 Lang Y; Li Y; Yu H; Lin L; Chen X; Wang S; Zhang H Aging (Albany NY); 2020 May; 12(9):7660-7678. PubMed ID: 32396526 [TBL] [Abstract][Full Text] [Related]
11. Mesencephalic astrocyte-derived neurotrophic factor alleviated 6-OHDA-induced cell damage via ROS-AMPK/mTOR mediated autophagic inhibition. Zhang J; Cai Q; Jiang M; Liu Y; Gu H; Guo J; Sun H; Fang J; Jin L Exp Gerontol; 2017 Mar; 89():45-56. PubMed ID: 28099881 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dysfunction and apoptosis are attenuated through activation of AMPK/GSK-3β/PP2A pathway in Parkinson's disease. Su J; Zhang J; Bao R; Xia C; Zhang Y; Zhu Z; Lv Q; Qi Y; Xue J Eur J Pharmacol; 2021 Sep; 907():174202. PubMed ID: 34048739 [TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine alleviates pain in MPTP-treated mice by activating the AMPK/mTOR/NF-κB pathways in astrocytes. Chen Y; Li Y; Li C; Zhu D; Cheng O; Cui J Neurosci Lett; 2022 Nov; 791():136933. PubMed ID: 36283628 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins. Kanagaraj N; Beiping H; Dheen ST; Tay SS Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712 [TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis in MPTP/MPP Qi H; Shen D; Jiang C; Wang H; Chang M Neurosci Lett; 2021 Jan; 741():135493. PubMed ID: 33181233 [TBL] [Abstract][Full Text] [Related]
16. LncRNA NEAT1 promotes MPP+ induced injury of PC12 cells and accelerates the progression of Parkinson's disease in mice through FUS mediated inhibition of PI3K/AKT/mTOR signalling pathway. Wang Y; Li Z; Li J; Sun C Exp Gerontol; 2024 Jun; 191():112436. PubMed ID: 38636570 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-599 regulates the development of Parkinson's disease through mediating LRRK2 expression. Wu Q; Xi DZ; Wang YH Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):724-731. PubMed ID: 30720180 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of NogoA prevents MPP+‑induced neurotoxicity in PC12 cells via the mTOR/STAT3 signaling pathway. Zhong J; Li X; Wan L; Chen Z; Zhong S; Xiao S; Yan Z Mol Med Rep; 2016 Feb; 13(2):1427-33. PubMed ID: 26648565 [TBL] [Abstract][Full Text] [Related]
19. lncRNA NEAT1 prompts autophagy and apoptosis in MPTP-induced Parkinson's disease by impairing miR-374c-5p. Dong LI; Zheng Y; Gao L; Luo X Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(7):870-882. PubMed ID: 33984130 [TBL] [Abstract][Full Text] [Related]
20. Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's disease. Xu Y; Liu C; Chen S; Ye Y; Guo M; Ren Q; Liu L; Zhang H; Xu C; Zhou Q; Huang S; Chen L Cell Signal; 2014 Aug; 26(8):1680-1689. PubMed ID: 24726895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]